249420.KS Ildong Pharmaceutical Co., Ltd. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
11:03
Aug 24
Lee Kwon-hee CEO, Economist 3PRO TV (삼프로TV)
Korean biotech is catching up with catalysts.
The biotech sector is attractive now because US biotech is at all-time highs despite high interest rates, and Korean biotech is catching up with individual catalysts like Hanmi Pharmaceutical's 3 trillion won technology export for an obesity drug and CuriOx Biosystems' global orders.
249420.KS 1ST
HIGH

About 249420.KS Analyst Coverage

Buzzberg tracks 249420.KS (Ildong Pharmaceutical Co., Ltd.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Lee Kwon-hee.